PharmTech News

Articles

Merck relaunches brand identity to reflect transformation into a science and technology company.

Merck Serono and Merck Millipore Become Merck

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Senator McCaskill deemed J. Michael Pearson’s response letter on drug pricing “inadequate.”

Valeant Addresses Questions on Pricing; Receives Subpoenas

Celebrating the best of pharma and recognizing companies that turn inspiration into innovation.

Meet the 2015 CPhI Pharma Awards Winners

Stefan Oschmann will replace new Karl-Ludwig Kley as chairman of the executive board and CEO of Merck KGaA.

Merck KGaA Appoints New CEO

Data protection for biologics is reduced from 12 to five years as a result of the Trans-Pacific Partnership agreement.

TPP Discussions Conclude; Biologics Now Have Shorter Data Protection Periods

Researchers in the US, Japan, and China are recognized for developing therapies to combat river blindness, lymphatic filariasis, and malaria.

Nobel Prize Awarded for Parasitic Disease Drug Development Efforts

CPhI’s Annual Report discusses the implications of QbD, continuous processing, excipient criticality, and process validation on pharmaceutical manufacturing and predicts a steady shift to continuous manufacturing.

CPhI Report Predicts Switch to Continuous Manufacturing

Democratic members of the House Committee on Oversight and Government Reform are requesting a subpoena for documents withheld by Valeant Pharmaceuticals.

Democrats Want to Subpoena Valeant Pharmaceuticals Over Drug Price Increase

The US Pharmacopeial Convention preposts its new chapter on sterile preparations for compounding pharmacies for public review.

USP Previews New Compounding Standards

Michael Kopcha has been named to lead CDER’s new Office of Pharmaceutical Quality.

Top News